Showing posts with label Celsion. Show all posts
Showing posts with label Celsion. Show all posts

Tuesday, November 15, 2011

Celsion (CLSN) (QSII) (CME) (REGN) (SLXP) (CMA) Ratings Reiterated

Celsion Co. (NASDAQ: CLSN), Quality Systems Inc. (NASDAQ: QSII), CME Group Inc. (NYSE: CME), Regeneron Pharma (NASDAQ: REGN), Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and Comerica (NYSE: CMA) had ratings on them reiterated by analysts.

Rodman & Renshaw reiterated its "Outperform" rating on Celsion Co. (CLSN). They have a price target of $6.00 on the company.

Auriga reiterated its "Neutral" rating on Quality Systems Inc. (QSII). They have a price target of $42.00 on the company.

ISI Group reiterated its "Buy" rating on CME Group Inc. (CME). They have a price target of $310.00 on the company.

Stifel Nicolaus reiterated its "Hold" rating on Regeneron Pharma (REGN).

Jefferies (NYSE:JEF) reiterated its "Buy" rating on Salix Pharmaceuticals, Ltd. (SLXP). They have a price target of $42.00 on the company.

Sterne Agee reiterated its "Buy" rating on Comerica (CMA). They have a price target of $35.00 on the company.